Shitara K - Search Results

1

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial.

Fuchs CS, Doi T, Jang RW, Muro K, Satoh T, Machado M, Sun W, Jalal SI, Shah MA, Metges JP, Garrido M, Golan T, Mandala M, Wainberg ZA, Catenacci DV, Ohtsu A, Shitara K, Geva R, Bleeker J, Ko AH, Ku G, Philip P, Enzinger PC, Bang YJ, Levitan D, Wang J, Rosales M, Dalal RP, Yoon HH. Fuchs CS, et al. Among authors: shitara k. JAMA Oncol. 2018 May 10;4(5):e180013. doi: 10.1001/jamaoncol.2018.0013. Epub 2018 May 10. JAMA Oncol. 2018. PMID: 29543932 Free PMC article. Clinical Trial.

2

Pilot study of combination chemotherapy using irinotecan plus S-1 for metastatic pancreatic cancer.

Shitara K, Komatsu Y, Yuki S, Munakata M, Muto O, Shimaya S, Sakata Y. Shitara K, et al. Oncology. 2008;75(1-2):67-70. doi: 10.1159/000151742. Epub 2008 Aug 28. Oncology. 2008. PMID: 18753799 Clinical Trial.

3

Chemotherapy for gastric cancer that recurs after adjuvant chemotherapy with S-1.

Shitara K, Muro K, Ura T, Takahari D, Yokota T, Sawaki A, Kawai H, Ito S, Yamamura Y. Shitara K, et al. Jpn J Clin Oncol. 2008 Nov;38(11):786-9. doi: 10.1093/jjco/hyn096. Epub 2008 Sep 26. Jpn J Clin Oncol. 2008. PMID: 18820010

4

Neutropaenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX.

Shitara K, Matsuo K, Takahari D, Yokota T, Inaba Y, Yamaura H, Sato Y, Najima M, Ura T, Muro K. Shitara K, et al. Eur J Cancer. 2009 Jul;45(10):1757-63. doi: 10.1016/j.ejca.2009.01.019. Epub 2009 Feb 11. Eur J Cancer. 2009. PMID: 19217278

5

[Molecular targeted therapy in colorectal cancer and its resistance].

Shitara K, Muro K. Shitara K, et al. Gan To Kagaku Ryoho. 2009 Apr;36(4):557-66. Gan To Kagaku Ryoho. 2009. PMID: 19381027 Japanese.

6

Chemoradiotherapy for treatment of esophageal cancer in Japan: current status and perspectives.

Shitara K, Muro K. Shitara K, et al. Gastrointest Cancer Res. 2009 Mar;3(2):66-72. Gastrointest Cancer Res. 2009. PMID: 19461908 Free PMC article.

7

Case series of cetuximab monotherapy for patients with pre-treated colorectal cancer complicated with hyperbilirubinemia due to severe liver metastasis.

Shitara K, Takahari D, Yokota T, Shibata T, Ura T, Muro K, Inaba Y, Yamaura H, Sato Y, Najima M, Utsunomiya S. Shitara K, et al. Jpn J Clin Oncol. 2010 Mar;40(3):275-7. doi: 10.1093/jjco/hyp161. Epub 2009 Nov 28. Jpn J Clin Oncol. 2010. PMID: 19946122 No abstract available.

8

Phase II study of combination chemotherapy with irinotecan and cetuximab for pretreated metastatic colorectal cancer harboring wild-type KRAS.

Shitara K, Yokota T, Takahari D, Shibata T, Ura T, Utsunomiya S, Inaba Y, Yamaura H, Sato Y, Najima M, Kawai H, Tajika M, Sawaki A, Yatabe Y, Muro K. Shitara K, et al. Invest New Drugs. 2011 Aug;29(4):688-93. doi: 10.1007/s10637-009-9382-x. Epub 2010 Jan 14. Invest New Drugs. 2011. PMID: 20072801 Clinical Trial.

9

Was the unexpected result a response to reintroduction of effective chemotherapy?

Shitara K, Muro K. Shitara K, et al. Gastrointest Cancer Res. 2009 Sep;3(5):217-8. Gastrointest Cancer Res. 2009. PMID: 20084166 Free PMC article. No abstract available.

10

Heavy smoking history interacts with chemoradiotherapy for esophageal cancer prognosis: a retrospective study.

Shitara K, Matsuo K, Hatooka S, Ura T, Takahari D, Yokota T, Abe T, Kawai H, Tajika M, Kodaira T, Shinoda M, Tajima K, Muro K, Tanaka H. Shitara K, et al. Cancer Sci. 2010 Apr;101(4):1001-6. doi: 10.1111/j.1349-7006.2009.01466.x. Epub 2009 Dec 9. Cancer Sci. 2010. PMID: 20085588 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

456 results

Search Page